ALA 1.61% 15.3¢ arovella therapeutics limited

Ann: FY20 Annual Report to shareholders, page-31

  1. 201 Posts.
    lightbulb Created with Sketch. 28
    My pleasure...
    Attention: Mr Baker.
    I read on Fridays after market press release that your remuneration for the past 6 months was $270 00 .I note that you have no shares in this company but you are willing to accept a bonus . This practice is unethical and not in the best interests of shareholders. This is shameful and a poor reflection on your character.
    As I understand the situation to date, your claim to fame is the delivery of a failed, costly business acquisition. The ASX clearly viewed this as amateurish and not in the best interest of shareholders.
    The TGA approval was instigated by the previous CEO, so no credit there.
    I suggest this bonus be returned and you give shareholders real updates as to where previous deals are heading.
 
watchlist Created with Sketch. Add ALA (ASX) to my watchlist
(20min delay)
Last
15.3¢
Change
-0.003(1.61%)
Mkt cap ! $160.3M
Open High Low Value Volume
15.5¢ 15.5¢ 15.0¢ $82.79K 539.5K

Buyers (Bids)

No. Vol. Price($)
1 18124 15.0¢
 

Sellers (Offers)

Price($) Vol. No.
15.5¢ 108897 1
View Market Depth
Last trade - 15.46pm 12/07/2024 (20 minute delay) ?
ALA (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.